Business Description
Innovacell Inc
ISIN : JP3147850006
Total Employee Number:
48Description
Innovacell Inc is engaged in the development, manufacturing, and sale of regenerative medicine products for the treatment of conditions including fecal and urinary incontinence. Its activities include researching potential therapeutic candidates, developing formulations, and commercializing products in the markets. The company is working on the development and commercialization of the following three cell therapy pipelines targeting incontinence (fecal and urinary incontinence): ICEF15, ICEF16, and ICES13.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 5.02 | |||||
Equity-to-Asset | 0.78 | |||||
Debt-to-Equity | 0.23 | |||||
Debt-to-EBITDA | -1.19 | |||||
Piotroski F-Score | 4/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 55.33 | |||||
9-Day RSI | 54.47 | |||||
14-Day RSI | 54.51 | |||||
3-1 Month Momentum % | -4.42 | |||||
6-1 Month Momentum % | -43.29 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 24.75 | |||||
Quick Ratio | 24.69 | |||||
Cash Ratio | 23.11 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROE % | -53.05 | |||||
ROA % | -28.79 | |||||
ROIC % | -203 | |||||
ROC (Joel Greenblatt) % | -345.37 | |||||
ROCE % | -21.49 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PB Ratio | 2.75 | |||||
Price-to-Tangible-Book | 2.76 | |||||
EV-to-EBIT | -9.61 | |||||
EV-to-EBITDA | -9.61 | |||||
EV-to-FCF | -7.69 | |||||
| Price-to-Net-Current-Asset-Value | 2.94 | |||||
| Price-to-Net-Cash | 3.21 | |||||
Earnings Yield (Greenblatt) % | -10.41 | |||||
FCF Yield % | -7.78 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Innovacell Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil 円) | |||
| EPS (TTM) (円) | -70.311 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | 54.51 | ||
| 14-Day ATR (円) | 38.83154 | ||
| 20-Day SMA (円) | 569.2 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (円) | 377 - 1248 | ||
| Shares Outstanding (Mil) | 45.15 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Innovacell Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Innovacell Inc Stock Events
| Event | Date | Price (円) | ||
|---|---|---|---|---|
| No Event Data | ||||
Innovacell Inc Frequently Asked Questions
What is Innovacell Inc(TSE:504A)'s stock price today?
The current price of TSE:504A is 円583.00. The 52 week high of TSE:504A is 円1248.00 and 52 week low is 円377.00.
When is next earnings date of Innovacell Inc(TSE:504A)?
The next earnings date of Innovacell Inc(TSE:504A) is .
Does Innovacell Inc(TSE:504A) pay dividends? If so, how much?
Innovacell Inc(TSE:504A) does not pay dividend.
Press Release
| Subject | Date | ||
|---|---|---|---|
| EVERSANA Selected by Innovacell as Commercialization Partner to Advance Novel Cell Therapy ICEF15 in the United States | 2026-07-30 |
Articles on Innovacell Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers